SCHEMBL7983434

SCHEMBL7983434

Cc1cccc(Cl)c1Nc1nc2cc(N3CCN[C@H](C)C3)ccc2n2cncc12

nearest known ligand 0.84

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 0.84
SRC P12931 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7983021 1.00 LCK (0.84) LCKSRC
SCHEMBL7983017 1.00 LCK (0.84) LCKSRC
SCHEMBL21067953 0.94 LCK (0.84) LCKSRC
SCHEMBL7980086 0.91 LCK (1.00) LCKSRC
SCHEMBL7986880 0.89 LCK (1.00) LCK
SCHEMBL4038002 0.87 LCK (0.75) LCKSRC
SCHEMBL7987217 0.85 LCK (1.00) LCKSRC
SCHEMBL7983047 0.85 LCK (1.00) LCK
SCHEMBL7981745 0.85 LCK (0.86) LCK
SCHEMBL4036209 0.85 LCK (1.00) LCKSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed